Mariner, LLC Sarepta Therapeutics, Inc. Transaction History
Mariner, LLC
- $58.4 Billion
- Q4 2024
A detailed history of Mariner, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Mariner, LLC holds 8,042 shares of SRPT stock, worth $511,953. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,042
Previous 7,007
14.77%
Holding current value
$511,953
Previous $875,000
11.66%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding SRPT
# of Institutions
515Shares Held
86.3MCall Options Held
1.49MPut Options Held
1.26M-
Black Rock Inc. New York, NY10.3MShares$657 Million0.04% of portfolio
-
Capital International Investors Los Angeles, CA9.06MShares$577 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$575 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X04.33MShares$276 Million0.28% of portfolio
-
State Street Corp Boston, MA4.07MShares$259 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $5.57B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...